Documents
Application Sponsors
NDA 021029 | MERCK SHARP DOHME | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Prescription | 004 |
Prescription | 005 |
Prescription | 006 |
Application Products
001 | CAPSULE;ORAL | 5MG | 1 | TEMODAR | TEMOZOLOMIDE |
002 | CAPSULE;ORAL | 20MG | 1 | TEMODAR | TEMOZOLOMIDE |
003 | CAPSULE;ORAL | 100MG | 1 | TEMODAR | TEMOZOLOMIDE |
004 | CAPSULE;ORAL | 250MG | 1 | TEMODAR | TEMOZOLOMIDE |
005 | CAPSULE;ORAL | 140MG | 1 | TEMODAR | TEMOZOLOMIDE |
006 | CAPSULE;ORAL | 180MG | 1 | TEMODAR | TEMOZOLOMIDE |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 1999-08-11 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 2001-05-18 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 3 | AP | 2002-03-05 | PRIORITY |
LABELING; Labeling | SUPPL | 4 | AP | 2002-01-18 | STANDARD |
EFFICACY; Efficacy | SUPPL | 5 | AP | 2003-03-11 | PRIORITY |
LABELING; Labeling | SUPPL | 6 | AP | 2004-07-15 | STANDARD |
LABELING; Labeling | SUPPL | 7 | AP | 2004-06-29 | STANDARD |
EFFICACY; Efficacy | SUPPL | 8 | AP | 2005-03-15 | PRIORITY |
LABELING; Labeling | SUPPL | 9 | AP | 2005-03-30 | STANDARD |
LABELING; Labeling | SUPPL | 10 | AP | 2005-04-22 | STANDARD |
LABELING; Labeling | SUPPL | 11 | AP | 2006-03-31 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 12 | AP | 2006-10-19 | N/A |
LABELING; Labeling | SUPPL | 18 | AP | 2010-04-26 | STANDARD |
LABELING; Labeling | SUPPL | 20 | AP | 2011-02-04 | UNKNOWN |
LABELING; Labeling | SUPPL | 21 | AP | 2011-06-03 | UNKNOWN |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 22 | AP | 2013-01-08 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 24 | AP | 2014-03-20 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 25 | AP | 2013-10-10 | PRIORITY |
LABELING; Labeling | SUPPL | 26 | AP | 2014-05-05 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 27 | AP | 2014-09-19 | PRIORITY |
LABELING; Labeling | SUPPL | 28 | AP | 2015-04-02 | STANDARD |
LABELING; Labeling | SUPPL | 29 | AP | 2015-09-18 | STANDARD |
LABELING; Labeling | SUPPL | 30 | AP | 2017-02-24 | STANDARD |
LABELING; Labeling | SUPPL | 31 | AP | 2016-02-12 | STANDARD |
LABELING; Labeling | SUPPL | 32 | AP | 2017-10-06 | STANDARD |
LABELING; Labeling | SUPPL | 33 | AP | 2019-11-22 | STANDARD |
LABELING; Labeling | SUPPL | 35 | AP | 2020-11-20 | STANDARD |
Submissions Property Types
ORIG | 1 | Orphan | 5 |
SUPPL | 2 | Null | 14 |
SUPPL | 3 | Null | 14 |
SUPPL | 5 | Null | 8 |
SUPPL | 8 | Null | 41 |
SUPPL | 18 | Null | 6 |
SUPPL | 20 | Null | 7 |
SUPPL | 21 | Null | 6 |
SUPPL | 22 | Null | 14 |
SUPPL | 24 | Null | 14 |
SUPPL | 25 | Null | 14 |
SUPPL | 26 | Null | 7 |
SUPPL | 27 | Null | 14 |
SUPPL | 28 | Null | 6 |
SUPPL | 29 | Null | 6 |
SUPPL | 30 | Null | 7 |
SUPPL | 31 | Null | 7 |
SUPPL | 32 | Null | 15 |
SUPPL | 33 | Null | 15 |
SUPPL | 35 | Null | 15 |
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
004 | Prescription | AB |
005 | Prescription | AB |
006 | Prescription | AB |
CDER Filings
MERCK SHARP DOHME
cder:Array
(
[0] => Array
(
[ApplNo] => 21029
[companyName] => MERCK SHARP DOHME
[docInserts] => ["",""]
[products] => [{"drugName":"TEMODAR","activeIngredients":"TEMOZOLOMIDE","strength":"5MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"TEMODAR","activeIngredients":"TEMOZOLOMIDE","strength":"20MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"TEMODAR","activeIngredients":"TEMOZOLOMIDE","strength":"100MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"TEMODAR","activeIngredients":"TEMOZOLOMIDE","strength":"250MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"},{"drugName":"TEMODAR","activeIngredients":"TEMOZOLOMIDE","strength":"140MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"TEMODAR","activeIngredients":"TEMOZOLOMIDE","strength":"180MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"}]
[labels] => [{"actionDate":"11\/22\/2019","submission":"SUPPL-33","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/021029s033lbl.pdf\"}]","notes":""},{"actionDate":"10\/06\/2017","submission":"SUPPL-32","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/021029s032lbl.pdf\"}]","notes":""},{"actionDate":"02\/24\/2017","submission":"SUPPL-30","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/021029s030lbl.pdf\"}]","notes":""},{"actionDate":"02\/12\/2016","submission":"SUPPL-31","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/021029s031lbl.pdf\"}]","notes":""},{"actionDate":"09\/18\/2015","submission":"SUPPL-29","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/021029s029lbl.pdf\"}]","notes":""},{"actionDate":"04\/02\/2015","submission":"SUPPL-28","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/021029s028lbl.pdf\"}]","notes":""},{"actionDate":"04\/02\/2015","submission":"SUPPL-28","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/021029s028lbl.pdf\"}]","notes":""},{"actionDate":"05\/05\/2014","submission":"SUPPL-26","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/021029s026lbl.pdf\"}]","notes":""},{"actionDate":"01\/08\/2013","submission":"SUPPL-22","supplementCategories":"Manufacturing (CMC)","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/021029s022lbl.pdf\"}]","notes":"This supplement type does not usually require new labeling."},{"actionDate":"06\/03\/2011","submission":"SUPPL-21","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/021029s021,022277s005lbl.pdf\"}]","notes":""},{"actionDate":"02\/04\/2011","submission":"SUPPL-20","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/021029s020,022277s004lbl.pdf\"}]","notes":""},{"actionDate":"04\/26\/2010","submission":"SUPPL-18","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/021029s018lbl.pdf\"}]","notes":""},{"actionDate":"10\/19\/2006","submission":"SUPPL-12","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/021029s012lbl.pdf\"}]","notes":""},{"actionDate":"10\/19\/2006","submission":"SUPPL-12","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/021029s012lbl.pdf\"}]","notes":""},{"actionDate":"03\/15\/2005","submission":"SUPPL-8","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/021029s008lbl.pdf\"}]","notes":""},{"actionDate":"03\/11\/2003","submission":"SUPPL-5","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/21029se8-005_temodar_lbl.pdf\"}]","notes":""},{"actionDate":"01\/18\/2002","submission":"SUPPL-4","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2002\\\/021029-S004_TEMODAR_lbl.pdf\"}]","notes":""},{"actionDate":"08\/11\/1999","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/1999\\\/21029lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"TEMODAR","submission":"TEMOZOLOMIDE","actionType":"5MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"TEMODAR","submission":"TEMOZOLOMIDE","actionType":"20MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"TEMODAR","submission":"TEMOZOLOMIDE","actionType":"100MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"TEMODAR","submission":"TEMOZOLOMIDE","actionType":"250MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"TEMODAR","submission":"TEMOZOLOMIDE","actionType":"140MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"TEMODAR","submission":"TEMOZOLOMIDE","actionType":"180MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 2019-11-22
)
)